⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for refractory myasthenia gravis

Every month we try and update this database with for refractory myasthenia gravis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia GravisNCT00424489
Myasthenia Grav...
Hematopoietic S...
Cyclophosphamid...
ATG (rabbit)
Mesna
Methylprednisol...
G-CSF
15 Years - 65 YearsNorthwestern University
A Pilot Trial of Rituxan in Refractory Myasthenia GravisNCT00619671
Refractory Myas...
Rituximab (Ritu...
18 Years - 80 YearsUniversity of Vermont
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia GravisNCT00424489
Myasthenia Grav...
Hematopoietic S...
Cyclophosphamid...
ATG (rabbit)
Mesna
Methylprednisol...
G-CSF
15 Years - 65 YearsNorthwestern University
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia GravisNCT00424489
Myasthenia Grav...
Hematopoietic S...
Cyclophosphamid...
ATG (rabbit)
Mesna
Methylprednisol...
G-CSF
15 Years - 65 YearsNorthwestern University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: